Cargando…
Lack of in Vivo Antibody Dependent Cellular Cytotoxicity with Antibody Containing Gold Nanoparticles
[Image: see text] Antibody-dependent cellular cytotoxicity (ADCC) is a cytolytic mechanism that can elicit in vivo antitumor effects and can play a significant role in the efficacy of antibody treatments for cancer. Here, we prepared cetuximab, panitumumab, and rituximab containing gold nanoparticle...
Autores principales: | Ahmed, Marya, Pan, Dorothy W., Davis, Mark E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2015
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4445771/ https://www.ncbi.nlm.nih.gov/pubmed/25879583 http://dx.doi.org/10.1021/acs.bioconjchem.5b00139 |
Ejemplares similares
-
Antibody-dependent cellular cytotoxicity in cancer patients: lack of prognostic value
por: McCredie, J. A., et al.
Publicado: (1980) -
Size- and cell type-dependent cellular uptake, cytotoxicity and in vivo distribution of gold nanoparticles
por: Xia, Qiyue, et al.
Publicado: (2019) -
Influenza and Antibody-Dependent Cellular Cytotoxicity
por: Von Holle, Tarra A., et al.
Publicado: (2019) -
Antibody targeting of Cathepsin S induces antibody-dependent cellular cytotoxicity
por: Kwok, Hang Fai, et al.
Publicado: (2011) -
Antibody–receptor interactions mediate antibody-dependent cellular cytotoxicity
por: Sun, Yue, et al.
Publicado: (2021)